Answers are grounded in this paper and cite their sources.
This cohort study reveals quality of life variations in neuroendocrine tumor patients, highlighting the need for ongoing assessments.
This large U.S. cohort reveals persistent symptom burden and HRQoL variation by tumor site and disease duration, underscoring the need for longitudinal HRQoL assessment in NET care.
No takes yet. Share an insight, caveat, or question.
O’Rorke et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: